Diamond Pharma Services   Report issue

For profit Phase 1 Phase 3
Founded: Harlow United Kingdom (2005)

Organization Overview

First Clinical Trial
2015
NCT02279524
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Diamond Pharma Services Regulatory Affairs Consultancy

Active Ingredients

Drugs in Phase 3 Trials (1)

aramchol (4 trials)

Drugs in Phase 1 Trials (3)

atorvastatin (lipitor) (1 trial)

azathioprine (imuran) (1 trial)

midazolam (versed) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatty Liver (Phase 3)

Malnutrition (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 4